Related Experiment Videos
CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression
K Honey1, S P Cobbold, H Waldmann
1Sir William Dunn School of Pathology, Oxford, United Kingdom.
Journal of Immunology (Baltimore, Md. : 1950)
|October 21, 1999
Summary
Blocking CD40-CD40 ligand (CD40L) with antibodies prolongs graft survival but doesn't induce tolerance alone. Controlling CD8+ T cells alongside CD40L blockade is crucial for achieving transplantation tolerance.
Area of Science:
- Immunology
- Transplantation Biology
- Autoimmune Diseases
Background:
- The CD40-CD40 ligand (CD40L) interaction is critical for adaptive immune responses.
- CD40L blockade has shown promise in experimental models of transplantation and autoimmunity, prolonging graft survival but not inducing tolerance.
- Previous studies suggest that CD8+ T cells may hinder tolerance induction.
Purpose of the Study:
- To investigate the role of CD8+ T cells in the failure to achieve transplantation tolerance with CD40L blockade.
- To explore the mechanisms underlying tolerance induction when CD8+ T cell responses are controlled.
- To characterize the regulatory properties of CD4+ T cells following CD40L blockade therapy.
Main Methods:
- Rodent models of allogeneic tissue transplantation.
- Treatment with anti-CD40L antibodies (Abs) and anti-CD8 Abs.
- Assessment of graft survival and induction of tolerance.
- Analysis of CD4+ T cell regulatory functions, including linked suppression.
Main Results:
- Anti-CD40L Abs alone prolonged graft survival but did not prevent rejection mediated by CD8+ T cells.
- Simultaneous blockade of CD8+ T cell responses with anti-CD8 Abs enabled the induction of transplantation tolerance.
- Tolerant CD4+ T cells induced by anti-CD40L therapy exhibited linked suppression, accepting third-party antigens presented with tolerated antigens.
- This linked suppression indicates a dominant regulatory mechanism maintaining the tolerant state.
Conclusions:
- CD40L blockade alone is insufficient to induce transplantation tolerance due to the involvement of CD8+ T cells.
- Controlling CD8+ T cell responses is essential for achieving tolerance via CD40L blockade.
- CD40L blockade can induce regulatory CD4+ T cells that mediate dominant tolerance through mechanisms like linked suppression.
- Combination therapies targeting both CD40L and CD8+ T cells may be necessary for effective clinical immunotherapeutics in transplantation.